CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,083,425 | +34.8% | 2,285,944 | -1.0% | 0.00% | +100.0% |
Q2 2023 | $25,277,998 | +333.3% | 2,308,493 | +245.0% | 0.00% | – |
Q1 2023 | $5,833,994 | +37.5% | 669,036 | -1.1% | 0.00% | – |
Q4 2022 | $4,241,944 | +258.3% | 676,546 | +100.0% | 0.00% | – |
Q3 2022 | $1,184,000 | +10.9% | 338,273 | -6.6% | 0.00% | – |
Q2 2022 | $1,068,000 | -74.7% | 362,120 | -73.3% | 0.00% | – |
Q1 2022 | $4,224,000 | -6.3% | 1,358,050 | +1.8% | 0.00% | – |
Q4 2021 | $4,509,000 | -3.3% | 1,333,890 | +4.5% | 0.00% | – |
Q3 2021 | $4,661,000 | -21.2% | 1,276,967 | -5.9% | 0.00% | – |
Q2 2021 | $5,917,000 | +1.0% | 1,357,224 | +5.1% | 0.00% | – |
Q1 2021 | $5,860,000 | -43.5% | 1,290,846 | -28.6% | 0.00% | -100.0% |
Q4 2020 | $10,380,000 | -12.6% | 1,808,347 | +10.2% | 0.00% | 0.0% |
Q3 2020 | $11,877,000 | +140.6% | 1,640,514 | +16.0% | 0.00% | – |
Q2 2020 | $4,937,000 | +134.6% | 1,414,471 | -0.5% | 0.00% | – |
Q1 2020 | $2,104,000 | -23.9% | 1,421,566 | +0.8% | 0.00% | – |
Q4 2019 | $2,763,000 | -65.9% | 1,409,914 | -10.8% | 0.00% | -100.0% |
Q3 2019 | $8,097,000 | -29.6% | 1,581,453 | -1.5% | 0.00% | 0.0% |
Q2 2019 | $11,501,000 | -31.5% | 1,606,334 | +27.0% | 0.00% | 0.0% |
Q1 2019 | $16,796,000 | +66.4% | 1,264,755 | -1.4% | 0.00% | 0.0% |
Q4 2018 | $10,092,000 | -30.7% | 1,282,395 | -2.5% | 0.00% | 0.0% |
Q3 2018 | $14,571,000 | -17.8% | 1,315,230 | -0.5% | 0.00% | 0.0% |
Q2 2018 | $17,734,000 | +483.7% | 1,321,563 | +465.3% | 0.00% | – |
Q1 2018 | $3,038,000 | +642.8% | 233,790 | +425.1% | 0.00% | – |
Q4 2017 | $409,000 | +46.6% | 44,522 | +28.3% | 0.00% | – |
Q3 2017 | $279,000 | – | 34,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |